MED22 and hepatocellular carcinoma: We assessed the expression levels of ME1, MED10, and MED22 in HCC and normal tissues using data from TCGA and HPA and found that they were highly expressed in HCC tissues, both at the mRNA and protein levels (Fig. 2a, b).